January 21, 2021 4:10 a.m.

State health officials in Oregon recommend that local vaccination sites continue to administer COVID-19 vaccines from Moderna Lot 041L20A, after they received advice from federal officials to continue to dispense the doses.

A release from the Oregon Health Authority said that lot has been associated with six adverse events at a single site in California.

Earlier this week, medical experts from the Western States Scientific Safety Review Committee evaluated the reports and will be following up with an announcement, reaffirming the CDC recommendations to continue to administer doses from this Moderna lot of vaccine.

OHA said that lot consists of approximately one million doses of vaccines. In Oregon, over 57,000 doses from the lot have been distributed to 118 vaccination sites. As of Wednesday, Oregon vaccination sites had administered 30,803 doses from the lot. OHA continues to monitor adverse events following administration of all COVID-19 vaccinations and is currently investigating two adverse events at separate sites linked to this Moderna lot. All individuals reported to OHA who experienced adverse events have recovered.

The release said their expectations are that local vaccination sites monitor patients for 15 minutes after vaccination, or 30 minutes in persons with a history of an immediate allergic reaction of any severity to a vaccine.

Dr. Dean Sidelinger, state health officer for Oregon said he continues to encourage every eligible Oregonian to get a vaccine as soon as it is available to them.